\n\tBodycote, England, announces that its facility in Ipswich, Mass., has earned MedAccred accreditation, underlining its high standards of quality.<\/p>\n
\n\tMedAccred, administered by the Performance Review Institute (PRI), is an industry-managed approach to ensuring critical manufacturing process quality throughout the medical device supply chain. It establishes stringent consensus audit criteria based on industry and specific OEM requirements that ensure compliance and quality. Adherence to these requirements leads to greater process discipline, operational efficiency and ongoing improvement which results in higher quality and performance.<\/p>\n
\n\tStrategically located in New England, Bodycote’s plant in Ipswich is fast becoming a center of excellence for the region’s medical device and implants market, offering heat treatment services to process and strengthen medical implants, surgical and dental tools, and other medical devices. The plant’s close proximity to Bodycote’s hot isostatic pressing (HIP) plant in Andover makes it an ideal source for a complete thermal processing solution.<\/p>\n
\n\tBodycote continues to invest in new capacity and technology to support opportunities within the growing medical industry for classic heat treatment and HIP, along with its Specialty Stainless Steel Processes (S3P) in North America. For Bodycote, the benefits of MedAccred to the supplier are evident. The process provides for consistent and standardized critical process audits, which result in fewer redundant onsite audits by multiple OEMs and first tier customers. The MedAccred certification reinforces customer confidence in Bodycote as a premier quality provider of heat treating.<\/p>\n